logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
23/02/2026
Chairman of the German Banking Association: Concerned about new tariff turmoil sparked by Washington.
Latest
5 m ago
U.S. treasuries rise; 10-year treasury yield falls to intraday low of 4.05%
7 m ago
Waller: If productivity is rising, the neutral interest rate may also be rising.
9 m ago
Federal Reserve Governor Wall: The scarce reserve system is inefficient and "stupid".
9 m ago
After the next-generation weight-loss drug CagriSema from Novo Nordisk failed to meet the key target of proving its effectiveness is not inferior to the competitor drug Victoza from Novo Nordisk, the company's stock plummeted by 14.5% in pre-market trading in the United States. Victoza is the active ingredient in Novo Nordisk's flagship drugs Mounjaro and Zepbound.
9 m ago
Goldman Sachs predicts that the economy will rebound in the first quarter after the government shutdown; moderate growth expected in 2026.
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.